Table 4 Per-lesion sensitivity for aNC-MRI for LI-RADS 4, 5 and M categories full protocol including contrast-enhanced sequences

 All malignant lesions (n = 42)

97/126, 77.0% (68.5–83.8%)

 < 20 mm

33/51, 64.7% (50.0–77.2%)

 ≥ 20 mm

64/75, 85.3% (74.8–92.1%)

 All malignant lesions

29/42, 69.0% (52.8–81.9%)

 < 20 mm

10/17, 58.9% (33.5–80.6%)

 ≥ 20 mm

19/25, 76.0% (54.5–89.8%)

 All malignant lesions

28/42, 66.7% (50.4–80.0%)

 < 20 mm

7/17, 41.2% (19.4–66.5%)

 ≥ 20 mm

21/25, 84.0% (63.1–94.7%)

 All malignant lesions

40/42, 95.2% (82.6–99.2%)

 < 20 mm

16/17, 94.1% (68.2–99.7%)

 ≥ 20 mm

24/25, 96.0% (77.7–99.8%)